KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Total Liabilities (2016 - 2025)

Medpace Holdings (MEDP) has disclosed Total Liabilities for 11 consecutive years, with $1.5 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities rose 18.9% year-over-year to $1.5 billion, compared with a TTM value of $1.5 billion through Dec 2025, up 18.9%, and an annual FY2025 reading of $1.5 billion, up 18.9% over the prior year.
  • Total Liabilities was $1.5 billion for Q4 2025 at Medpace Holdings, up from $1.5 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $1.5 billion in Q4 2025 and bottomed at $592.4 million in Q1 2021.
  • Average Total Liabilities over 5 years is $1.0 billion, with a median of $1.0 billion recorded in 2022.
  • The sharpest move saw Total Liabilities surged 67.07% in 2022, then dropped 1.58% in 2023.
  • Year by year, Total Liabilities stood at $707.0 million in 2021, then soared by 36.65% to $966.1 million in 2022, then grew by 13.64% to $1.1 billion in 2023, then grew by 16.16% to $1.3 billion in 2024, then increased by 18.9% to $1.5 billion in 2025.
  • Business Quant data shows Total Liabilities for MEDP at $1.5 billion in Q4 2025, $1.5 billion in Q3 2025, and $1.4 billion in Q2 2025.